Literature DB >> 12847676

Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.

Inmaculada Del Rincón1, Ken Williams, Michael P Stern, Gregory L Freeman, Daniel H O'Leary, Agustín Escalante.   

Abstract

OBJECTIVE: To examine the relationship between markers of systemic inflammation and carotid atherosclerosis in patients with rheumatoid arthritis (RA) and healthy controls.
METHODS: Carotid artery intima-media thickness (IMT) and carotid plaque were measured using high-resolution B-mode ultrasound in 204 patients with RA, ages 40-85, and 102 age- and sex-matched healthy persons. No subject in either group had ever smoked cigarettes. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were used to measure systemic inflammation. The relationship of the carotid artery IMT and carotid plaque to inflammation markers was examined, adjusting for age, sex, RA versus control status, and the cardiovascular (CV) risk factors hypercholesterolemia, systolic blood pressure, diabetes mellitus, and body mass index (BMI).
RESULTS: A significant linear trend for increased carotid artery IMT was associated with increasing ESR and CRP categories (r = 0.16, P = 0.004 for ESR, and r = 0.13, P = 0.02 for CRP). These trends did not differ among RA cases and controls, and were independent of age, sex, and CV risk factors. The difference in carotid artery IMT between the lowest and highest categories of ESR was 0.221 mm (95% confidence interval [95% CI] 0.767-1.020, P = 0.02). The difference between extreme CRP categories was 0.275 mm (95% CI 0.039-0.509, P = 0.02). Both remained significant after CV risk factor adjustment. Carotid plaque displayed a similar relationship to markers of inflammation.
CONCLUSION: Increased carotid artery IMT and the presence of carotid plaque are associated with markers of systemic inflammation in patients with RA and in healthy subjects. This observation is consistent with hypotheses that assign a role to systemic inflammation in atherosclerosis, and may have implications regarding RA and other chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847676     DOI: 10.1002/art.11078

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  116 in total

1.  Accelerated atherosclerosis in patients with Wegener's granulomatosis.

Authors:  K de Leeuw; J-S Sanders; C Stegeman; A Smit; C G Kallenberg; M Bijl
Journal:  Ann Rheum Dis       Date:  2004-09-16       Impact factor: 19.103

2.  Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Authors:  Leonel Daza; Martin Aguirre; Martin Jimenez; Rafael Herrera; J J Bollain
Journal:  Clin Rheumatol       Date:  2006-06-07       Impact factor: 2.980

3.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

4.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

5.  Atherosclerosis in Takayasu arteritis.

Authors:  E Seyahi; S Ugurlu; R Cumali; H Balci; N Seyahi; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

6.  Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.

Authors:  Hamada M M Sayed Ahmed; Mahmoud Youssef; Youssef M Mosaad
Journal:  Clin Rheumatol       Date:  2010-03-31       Impact factor: 2.980

Review 7.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

Review 8.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

9.  Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

Authors:  Zurab Nadareishvili; Kaleb Michaud; John M Hallenbeck; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-08-15

10.  Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.

Authors:  Peng Wang; Shi-Yang Guan; Shu-Zhen Xu; Hong-Miao Li; Rui-Xue Leng; Xiang-Pei Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2015-11-27       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.